Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT05415722 | DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis | PHASE2 | COMPLETED | 162 | — | — | Jun 1, 2022 | Jul 1, 2023 | Mar 11, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| TERN-501 | DRUG | Investigational drug |
| TERN-101 | DRUG | Investigational drug |
| Placebo | OTHER | Matching placebo |